Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Wadsworth JD, Joiner S, Linehan JM, Desbruslais M, Fox K, Cooper S, Cronier S, Asante EA, Mead S, Brandner S, Hill AF, Collinge J.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3885-90. doi: 10.1073/pnas.0800190105. Epub 2008 Mar 3.

2.

Review. The origin of the prion agent of kuru: molecular and biological strain typing.

Wadsworth JD, Joiner S, Linehan JM, Asante EA, Brandner S, Collinge J.

Philos Trans R Soc Lond B Biol Sci. 2008 Nov 27;363(1510):3747-53. doi: 10.1098/rstb.2008.0069. Review.

3.

Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A, Zou WQ, Kretzschmar H, Ghetti B, Brown P.

Brain. 2010 Oct;133(10):3030-42. doi: 10.1093/brain/awq234. Epub 2010 Sep 7.

4.

A naturally occurring variant of the human prion protein completely prevents prion disease.

Asante EA, Smidak M, Grimshaw A, Houghton R, Tomlinson A, Jeelani A, Jakubcova T, Hamdan S, Richard-Londt A, Linehan JM, Brandner S, Alpers M, Whitfield J, Mead S, Wadsworth JD, Collinge J.

Nature. 2015 Jun 25;522(7557):478-81. doi: 10.1038/nature14510. Epub 2015 Jun 10.

5.

Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.

Kobayashi A, Parchi P, Yamada M, Mohri S, Kitamoto T.

Neuropathology. 2016 Jun;36(3):305-10. doi: 10.1111/neup.12270. Epub 2015 Dec 15. Review.

PMID:
26669818
6.

The kuru infectious agent is a unique geographic isolate distinct from Creutzfeldt-Jakob disease and scrapie agents.

Manuelidis L, Chakrabarty T, Miyazawa K, Nduom NA, Emmerling K.

Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13529-34. doi: 10.1073/pnas.0905825106. Epub 2009 Jul 24.

7.

Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.

Asante EA, Gowland I, Grimshaw A, Linehan JM, Smidak M, Houghton R, Osiguwa O, Tomlinson A, Joiner S, Brandner S, Wadsworth JD, Collinge J.

J Gen Virol. 2009 Mar;90(Pt 3):546-58. doi: 10.1099/vir.0.007930-0.

8.

Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.

Galeno R, Di Bari MA, Nonno R, Cardone F, Sbriccoli M, Graziano S, Ingrosso L, Fiorini M, Valanzano A, Pasini G, Poleggi A, Vinci R, Ladogana A, Puopolo M, Monaco S, Agrimi U, Zanusso G, Pocchiari M.

J Virol. 2017 May 12;91(11). pii: e02390-16. doi: 10.1128/JVI.02390-16. Print 2017 Jun 1.

9.

Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection.

Hizume M, Kobayashi A, Teruya K, Ohashi H, Ironside JW, Mohri S, Kitamoto T.

J Biol Chem. 2009 Feb 6;284(6):3603-9. doi: 10.1074/jbc.M809254200. Epub 2008 Dec 10.

10.

BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.

Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JD, Collinge J.

EMBO J. 2002 Dec 2;21(23):6358-66.

11.

Human prion diseases: from Kuru to variant Creutzfeldt-Jakob disease.

Sikorska B, Liberski PP.

Subcell Biochem. 2012;65:457-96. doi: 10.1007/978-94-007-5416-4_17. Review.

PMID:
23225013
12.

Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.

Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J, Norsworthy P, Hummerich H, Druyeh R, Wadsworth JD, Brandner S, Hyare H, Mead S, Collinge J.

Brain. 2015 Nov;138(Pt 11):3386-99. doi: 10.1093/brain/awv235. Epub 2015 Aug 11.

13.

Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?

Kobayashi A, Parchi P, Yamada M, Brown P, Saverioni D, Matsuura Y, Takeuchi A, Mohri S, Kitamoto T.

J Virol. 2015 Apr;89(7):3939-46. doi: 10.1128/JVI.03183-14. Epub 2015 Jan 21.

14.

A history of kuru.

Alpers MP.

P N G Med J. 2007 Mar-Jun;50(1-2):10-9.

PMID:
19354007
15.

Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.

Brandner S, Whitfield J, Boone K, Puwa A, O'Malley C, Linehan JM, Joiner S, Scaravilli F, Calder I, P Alpers M, Wadsworth JD, Collinge J.

Philos Trans R Soc Lond B Biol Sci. 2008 Nov 27;363(1510):3755-63. doi: 10.1098/rstb.2008.0091.

16.

Kuru: genes, cannibals and neuropathology.

Liberski PP, Sikorska B, Lindenbaum S, Goldfarb LG, McLean C, Hainfellner JA, Brown P.

J Neuropathol Exp Neurol. 2012 Feb;71(2):92-103. doi: 10.1097/NEN.0b013e3182444efd. Review.

17.

A traceback phenomenon can reveal the origin of prion infection.

Kobayashi A, Asano M, Mohri S, Kitamoto T.

Neuropathology. 2009 Oct;29(5):619-24. doi: 10.1111/j.1440-1789.2008.00973.x. Epub 2009 Jul 29.

PMID:
19659941
18.

Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques.

Kitamoto T, Tateishi J, Sawa H, Doh-Ura K.

Lab Invest. 1989 Apr;60(4):507-12.

PMID:
2468821
19.

Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.

Kobayashi A, Matsuura Y, Iwaki T, Iwasaki Y, Yoshida M, Takahashi H, Murayama S, Takao M, Kato S, Yamada M, Mohri S, Kitamoto T.

Brain Pathol. 2016 Jan;26(1):95-101. doi: 10.1111/bpa.12264. Epub 2015 Jun 4.

PMID:
25851836
20.

Human prion protein with valine 129 prevents expression of variant CJD phenotype.

Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF, Brandner S, Collinge J.

Science. 2004 Dec 3;306(5702):1793-6. Epub 2004 Nov 11.

Supplemental Content

Support Center